NCT06570603 Targeting Components of Distress Tolerance
| NCT ID | NCT06570603 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arkansas, Fayetteville |
| Condition | Distress, Emotional |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-10-03 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2024-10-03 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn which aspects of distress intolerance (i.e., difficulties withstanding upsetting emotional states) are the most important for improving effective emotion regulation and associated mental health symptoms. The main questions it aims to answer are: How are willingness to feel upset and self-efficacy for withstanding distress associated with different emotion regulation strategies used in daily life? Does targeting willingness to feel upset and/or self-efficacy for withstanding distress help people use more effective emotion regulation strategies in daily life when they feel upset? Are improvements in emotion regulation strategies in daily life associated with fewer symptoms of mental health problems over time? Participants will: Answer questions about their moods, willingness to feel upset, self-efficacy for withstanding distress and emotion regulation strategies for three weeks using a cell phone app Undergo a willingness, self-efficacy, combined or psychoeducational control intervention in the lab Be prompted to use the intervention skill via the cell phone app during the second week, after the intervention Complete weekly reports of mental health symptoms
Eligibility Criteria
Inclusion Criteria: * Fluent in English * Uses Android or iPhone smartphone * Depression Anxiety and Stress Scale (DASS-21) scores of 42 and higher * Distress Intolerance Index (DII) scores of 3 or higher Exclusion Criteria: * Work or School that does not allow consistent access to phone (or is unsafe) * No internet access for completing follow-up surveys
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06570603 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Distress, Emotional. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06570603 currently recruiting?
Yes, NCT06570603 is actively recruiting participants. Contact the research team at jcveille@uark.edu for enrollment information.
Where is the NCT06570603 trial being conducted?
This trial is being conducted at Fayetteville, United States.
Who is sponsoring the NCT06570603 clinical trial?
NCT06570603 is sponsored by University of Arkansas, Fayetteville. The trial plans to enroll 240 participants.